XM does not provide services to residents of the United States of America.

U.S. Array Technologies, Hess, Lennar



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Array Technologies, Hess, Lennar</title></head><body>

Sept 4 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Array Technologies,Hess and Lennar, on Wednesday.


HIGHLIGHTS


* Array Technologies Inc ARRY.O: Jefferies assumes coverage with buy vs hold rating; PT $11

* Airbnb Inc ABNB.O: Jefferies cuts target price to $120 from $125

* Hess HES.N: Susquehanna cuts target price to $149 from $151

* Lennar Corp LEN.N: KBW raises target price to $230 from $183

* Zscaler Inc ZS.O: Piper Sandler cuts target price to $215 from $255

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.


* Afc Gamma Inc AFCG.O: Jefferies cuts target price to $13 from $16

* Airbnb Inc ABNB.O: Jefferies cuts target price to $120 from $125

* Ameresco Inc AMRC.N: Jefferies initiates with hold rating; PT $33

* Apa Corporation APA.O: Susquehanna cuts target price to $52 from $57

* Array Technologies Inc ARRY.O: Jefferies assumes coverage with buy vs hold rating; PT $11

* Asana Inc ASAN.N: Baird cuts target price to $13 from $20

* Asana Inc ASAN.N: Piper Sandler cuts target price to $12 from $14

* Ascendis pharma A/S ASND.O: JP Morgan cuts target price to $165 from $174

* Athira pharma Inc ATHA.O: BTIG cuts to neutral from buy

* Booking Holdings Inc BKNG.O: Jefferies cuts target price to $4,200 from $4,350

* Booking Holdings Inc BKNG.O: Jefferies cuts to hold from buy

* Bridgebio pharma Inc BBIO.O: Piper Sandler initiates coverage with overweight rating; PT$46

* Caseys General Stores Inc CASY.O: JP Morgan raises PT to $300 from $298

* Conocophillips COP.N: Susquehanna cuts PT to $147 from $154

* Constellation Brands Inc STZ.N: Jefferies cuts PT to $310 from $311

* Constellation Brands Inc STZ.N: JP Morgan cuts PT to $307 from $320

* Constellation Brands Inc STZ.N: Roth MKM cuts target price to $298 from $303

* Copt Defense Properties CDP.N: JP Morgan raises target price to $31 from $26

* Coterra Energy Inc CTRA.N: Susquehanna cuts target price to $30 from $33

* Devon Energy Corp DVN.N: Susquehanna cuts target price to $63 from $65

* Diamondback Energy Inc FANG.O: Susquehanna cuts target price to $237 from $245

* Enphase Energy Inc ENPH.O: Jefferies assumes coverage with hold rating; PT $115 vs $111

* EOG Resources Inc EOG.N: Susquehanna cuts target price to $158 from $159

* Fidelity National Financial Inc FNF.N: KBW raises target price to $63 from $58

* First American Financial Corp FAF.N: KBW raises target price to $72 from $66

* First Solar Inc FSLR.O: Jefferies raises target price to $271 from $258

* Fluence Energy Inc FLNC.O: Jefferies initiates coverage with buy rating; PT $26

* Freshpet Inc FRPT.O: TD Cowen raises target price to $160 from $143

* GE Vernova Inc GEV.N: Jefferies initiates with buy rating; price target $261

* Gitlab Inc GTLB.O: BTIG raises target price to $63 from $58

* Gitlab Inc GTLB.O: RBC raises target price to $60 from $55

* Guidewire Software Inc GWRE.N: Baird raises target price to $165 from $152

* Ha Sustainable Infrastructure Capital Inc HASI.N: Jefferies initiates with buy rating; PT $39

* Hess HES.N: Susquehanna cuts target price to $149 from $151

* Larimar Therapeutics Inc LRMR.O: Baird initiates coverage with outperform rating; PT $16

* Lennar Corp LEN.N: KBW raises target price to $230 from $183

* Magnolia Oil & Gas Corp MGY.N: Susquehanna cuts target price to $32 from $33

* Marathon Oil Corp MRO.N: Susquehanna cuts target price to $37 from $39

* Mitek Systems Inc MITK.O: Jefferies cuts to hold from buy; cuts PT to $9.5 from $17

* Nextracker Inc NXT.O: Jefferies initiates with hold rating; price target $46

* Nuvalent Inc NUVL.O: JP Morgan raises target price to $100 from $90

* Occidental Petroleum Corp OXY.N: Susquehanna cuts target price to $78 from $81

* Onestream Inc OS.O: Piper Sandler raises target price to $34 from $32

* Oruka Therapeutics Inc ORKA.O: Wedbush initiates coverage with outperform rating; PT $40

* Pagerduty Inc PD.N: Baird cuts target price to $18 from $22

* Pagerduty Inc PD.N: Canaccord Genuity cuts target price to $24 from $26

* Pagerduty Inc PD.N: JP Morgan cuts target price to $21 from $24

* Pagerduty Inc PD.N: RBC cuts target price to $22 from $27

* Pagerduty Inc PD.N: TD Cowen cuts target price to $19 from $23

* Permian Resources Corp PR.N: Susquehanna cuts target price to $15 from $16

* Plymouth Industrial REIT Inc PLYM.N: JP Morgan raises target price to $24 from $23

* Polestar PSNY.O: Piper Sandler cuts target price to $1.5 from $2

* PTC Therapeutics Inc PTCT.O: Baird initiates coverage with outperform rating;PT $44

* Quanta Services Inc PWR.N: Jefferies initiates coverage with t hold rating; PT $256

* Range Resources Corp RRC.N: Susquehanna cuts target price to $31 from $36

* Realty Income Corp O.N: JP Morgan raises target price to $67 from $60

* Recursion Pharmaceuticals Inc RXRX.O: Leerink Partners cuts PT to $8 from $9

* Sable Offshore Corp SOC.N: Jefferies raises target price to $32 from $19

* Shoals Technologies Group Inc SHLS.O: Jefferies initiates coverage with hold rating; PT$5

* Springworks Therapeutics Inc SWTX.O: JP Morgan raises target price to $68 from $64

* Spyre Therapeutics Inc SYRE.O: Wedbush initiates coverage with outperform rating; PT $45

* Stewart Information Services Corp STC.N: KBW raises PT to $75 from $71

* Sunoco LP SUN.N: JP Morgan raises target price to $63 from $61

* Sunrun Inc RUN.O: Jefferies raises target price to $31 from $26

* Transdigm Group Inc TDG.N: JP Morgan raises PT to $1,435 from $1,350

* Twfg Inc TWFG.O: KBW raises target price to $28 from $27

* Vaxcyte Inc PCVX.O: Leerink Partners raises PT to $153 from $106

* Vaxcyte Inc PCVX.O: Needham raises target price to $140 from $95

* Waldencast Plc WALD.O: D.A. Davidson raises PT to $7.25 from $6.50

* Walmart WMT.N: Jefferies raises target price to $90 from $85

* Zscaler Inc ZS.O: BTIG cuts target price to $205 from $220

* Zscaler Inc ZS.O: Jefferies cuts target price to $225 from $250

* Zscaler Inc ZS.O: Piper Sandler cuts target price to $215 from $255




(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.